CMS has suspended enrollment for two Medicare Advantage prescription drug plans offered by eternalHealth, a Boston-based insurer.
In March, Massachusetts regulators banned eternalHealth from marketing any of its products and services in the state and suspended new member agreements until further notice after the company failed to meet state financial solvency requirements.
“Because eternalHealth is not permitted to accept new enrollments under its license with the state of Massachusetts, it is non-compliant with CMS’ contract requirements,” CMS wrote April 3.
CMS’ sanction will remain in effect until Massachusetts regulators determine that eternalHealth can successfully operate under good standing and that the order has been removed.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
